Navidea Biopharmaceuticals Inc. announced that its board of directors has appointed board member Anton Gueth to the position of Chairman. Mr. Gueth succeeds Gordon Troup who joined Navidea's board of Directors in July 2008 and was named as Chairman of the Board in August 2011. Although Mr. Troup has stepped down as Chairman, he continues to serve as a director on the Board.

Mr. Gueth brings over 30 years of global finance and operating experience in the pharmaceutical and healthcare industries. He is currently Managing Director of EVOLUTION Life Science Partners. He is also the founder and Managing Partner of Gueth Consulting LLC and was previously a Managing Director of Burrill Securities.

His career includes nearly 19 years with Eli Lilly and Company (Lilly), most recently as director of Alliance Management.